No connection

Search Results

LFMD vs QTRX

LFMD
LifeMD, Inc.
BEARISH
Price
$3.47
Market Cap
$166.5M
Sector
Healthcare
AI Confidence
95%
QTRX
Quanterix Corporation
BEARISH
Price
$3.50
Market Cap
$164.3M
Sector
Healthcare
AI Confidence
85%

Valuation

P/E Ratio
LFMD
--
QTRX
--
Forward P/E
LFMD
7.8
QTRX
-1.83
P/B Ratio
LFMD
7.0
QTRX
0.55
P/S Ratio
LFMD
0.86
QTRX
1.18
EV/EBITDA
LFMD
-20.27
QTRX
-1.16

Profitability

Gross Margin
LFMD
85.72%
QTRX
46.77%
Operating Margin
LFMD
-2.34%
QTRX
-48.2%
Profit Margin
LFMD
7.4%
QTRX
-77.14%
ROE
LFMD
-131.16%
QTRX
-34.25%
ROA
LFMD
-6.54%
QTRX
-13.11%

Growth

Revenue Growth
LFMD
-27.1%
QTRX
24.7%
Earnings Growth
LFMD
--
QTRX
--

Financial Health

Debt/Equity
LFMD
0.27
QTRX
0.13
Current Ratio
LFMD
1.25
QTRX
2.84
Quick Ratio
LFMD
1.11
QTRX
1.98

Dividends

Dividend Yield
LFMD
--
QTRX
--
Payout Ratio
LFMD
0.0%
QTRX
0.0%

AI Verdict

LFMD BEARISH

LFMD exhibits severe financial deterioration, highlighted by a weak Piotroski F-Score of 2/9 and a catastrophic Q/Q revenue decline of 88.98%. While the company maintains a low debt-to-equity ratio, the combination of negative operating margins, a deeply negative ROE (-131.16%), and a 0/4 earnings beat record over the last four quarters indicates a business in crisis. Despite a high analyst target price of $9.88, the fundamental data and technical trend (0/100) suggest a value trap scenario.

Strengths
High gross margins (85.72%)
Low debt-to-equity ratio (0.27)
Reasonable current ratio (1.25)
Risks
Severe revenue collapse (-88.98% Q/Q)
Consistent earnings misses (0/4 beats in last 4 quarters)
Deeply negative Return on Equity (-131.16%)
QTRX BEARISH

QTRX exhibits severe financial distress as evidenced by a Piotroski F-Score of 1/9, indicating critical weakness in operational efficiency and financial health. While the company maintains strong top-line revenue growth (24.7% YoY) and a healthy current ratio (2.84), these are overshadowed by a devastating profit margin of -77.14% and a consistent track record of missing earnings estimates. The stock is in a clear long-term downtrend, having lost over 94% of its value over five years, and currently trades at a significant discount to book value (P/B 0.55), suggesting a 'value trap' scenario.

Strengths
Strong YoY revenue growth of 24.70%
Low leverage with a Debt/Equity ratio of 0.13
Strong short-term liquidity (Current Ratio 2.84)
Risks
Critical operational health (Piotroski F-Score 1/9)
Deeply negative profitability (Profit Margin -77.14%)
Poor earnings reliability (Average surprise -41.54% over last 4 quarters)

Compare Another Pair

LFMD vs QTRX: Head-to-Head Comparison

This page compares LifeMD, Inc. (LFMD) and Quanterix Corporation (QTRX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile